Data availability
The data in this study are available on reasonable request from the corresponding author [TMG] upon approval of the Institutional Review Board.
References
Boudreaux BW, Pincelli TP, Bhullar PK, Patel MH, Brumfiel CM, Li X, Heckman MG, Pittelkow MR, Mangold AR, Sluzevich JC (2022) Secukinumab for the treatment of adult-onset pityriasis rubra pilaris: a single-arm clinical trial with transcriptomic analysis. Br J Dermatol 187(5):650–658. https://doi.org/10.1111/bjd.21708
Chularojanamontri L, Griffiths CE, Chalmers RJ (2013) The Simplified Psoriasis Index (SPI): a practical tool for assessing psoriasis. J Invest Dermatol 133(8):1956–62. https://doi.org/10.1038/jid.2013.138
Haynes D, Strunck JL, Topham CA, Ortega-Loayza AG, Kent G, Cassidy PB, Hu R, Choate K, Wang Z, Liu Y, Greiling TM (2020) Evaluation of Ixekizumab treatment for patients with pityriasis rubra pilaris: a single-arm trial. JAMA Dermatol 156(6):668–675. https://doi.org/10.1001/jamadermatol.2020.0932
Ji-Xu A, Lei DK, Worswick S, Maloney NJ, Kim MM, Cutler L (2022) Patient and disease characteristics associated with psychiatric symptoms and impaired quality of life in pityriasis rubra pilaris. Br J Dermatol 187(6):1024–1026. https://doi.org/10.1111/bjd.21792. (Epub 2022 Aug 18 PMID: 35895853)
Velasco RC, Cutler B, McCue W, Greiling TM (2023) The comprehensive impact of pityriasis rubra pilaris on physical symptoms, mental health, and activities of daily living: a mixed methods study. JEADV Clin Pract. https://doi.org/10.1002/jvc2.107
Funding
Clinical data was collected while subjects were enrolled in investigator-initiated clinical trials funded by Eli Lilly and Co. and Janssen Scientific Affairs. The funders had no role in the collection or analysis of data, nor the decision to publish.
Author information
Authors and Affiliations
Contributions
Conceptualization: TG; Methodology: TG, CS; Formal analysis and investigation: all authors; Writing–original draft preparation: CS; Writing–reviewing and editing: all authors; Funding acquisition: TG.
Corresponding author
Ethics declarations
Conflict of interest
Teri Greiling has received research grants to study PRP from Eli Lilly and Co, Janssen Scientific Affairs, and Janssen Biotech Inc; consulted with AbbVie; and is an author on PRP for UpToDate and VisualDx. Connie Shao and Rose Velasco declare no conflicts of interest.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Shao, C., Velasco, R. & Greiling, T.M. The individual Pityriasis Rubra Pilaris area and severity index (iPRPASI): validity, reliability, and responsiveness of a novel patient-reported severity tool. Arch Dermatol Res 315, 2933–2935 (2023). https://doi.org/10.1007/s00403-023-02682-7
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00403-023-02682-7